CHAPEL HILL, N.C., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at the Jefferies 2013 London Healthcare Conference at 1 p.m. GMT, Wednesday, Nov. 20, at The Waldorf Hilton in London. Carl Foster, executive vice president, business development of Cempra, will present at the 2013 Therapeutic Area Partnerships (TAP) conference at 2:25 p.m. EST, Tuesday, Nov. 19, at The Hyatt Regency in Boston. Dr. Fernandes and Mr. Foster will discuss the company’s two differentiated antibiotics, solithromycin (CEM-101) for community-acquired bacterial pneumonia and TAKSTA (CEM-102 or fusidic acid) for the chronic, oral treatment of Gram-positive pathogens including methicillin-resistant S. aureus (MRSA) in prosthetic joint infections.
Help employers find you! Check out all the jobs and post your resume.
